These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11247546)

  • 1. Matrix metalloproteinases in pathophysiology and treatment of heart failure.
    Feldman AM; Li YY; McTiernan CF
    Lancet; 2001 Mar; 357(9257):654-5. PubMed ID: 11247546
    [No Abstract]   [Full Text] [Related]  

  • 2. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
    Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
    J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds.
    Mann DL; Spinale FG
    Circulation; 1998 Oct; 98(17):1699-702. PubMed ID: 9788821
    [No Abstract]   [Full Text] [Related]  

  • 4. Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy.
    Tozzi R; Palladini G; Fallarini S; Nano R; Gatti C; Presotto C; Schiavone A; Micheletti R; Ferrari P; Fogari R; Perlini S
    Am J Hypertens; 2007 Jun; 20(6):663-9. PubMed ID: 17531925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of MMPs and TIMPs in moderate and severe heart failure in a transgenic model.
    Mori S; Gibson G; McTiernan CF
    J Card Fail; 2006 May; 12(4):314-25. PubMed ID: 16679266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.
    Bhalla V; Georgiopoulou VV; Azeem AA; Marti CN; Cole RT; Laskar SR; De Staercke C; Hooper WC; Smith AL; Kalogeropoulos AP; Butler J
    Int J Cardiol; 2011 Sep; 151(2):237-9. PubMed ID: 21723628
    [No Abstract]   [Full Text] [Related]  

  • 7. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
    Saka M; Obata K; Ichihara S; Cheng XW; Kimata H; Nishizawa T; Noda A; Izawa H; Nagata K; Murohara T; Yokota M
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):770-9. PubMed ID: 16810078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metalloproteinases and their inhibitors: the importance of extracellular matrix degradation in malignancy].
    Sela B
    Harefuah; 2000 Dec; 139(11-12):446-51. PubMed ID: 11341192
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model.
    Salminen HJ; Säämänen AM; Vankemmelbeke MN; Auho PK; Perälä MP; Vuorio EI
    Ann Rheum Dis; 2002 Jul; 61(7):591-7. PubMed ID: 12079898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia.
    Lorenzl S; De Pasquale G; Segal AZ; Beal MF
    Stroke; 2003 Jun; 34(6):e37-8; author reply e37-8. PubMed ID: 12750528
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucosal expression of matrix metalloproteinases and their tissue inhibitors in ulcerative colitis patients.
    Kusugami K; Nobata K; Tsuzuki T; Ando T; Ina K
    J Gastroenterol; 2003; 38(4):412-3. PubMed ID: 12743787
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac remodeling in erythropoietin-transgenic mice.
    Briest W; Homagk L; Baba HA; Deten A; Rassler B; Tannapfel A; Wagner KF; Wenger RH; Zimmer HG
    Cell Physiol Biochem; 2004; 14(4-6):277-84. PubMed ID: 15319531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unifying role of matrix metalloproteinases in atheroma and vascular stroke.
    Tayebjee MH; Lip GY; MacFadyen RJ
    Stroke; 2004 Oct; 35(10):2239. PubMed ID: 15308790
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in invasion of tumours of neuroepithelial tissue].
    Bogaczewicz J; Jasielski P; Mosiewicz A; Trojanowski T; Suchozebrska-Jesionek D; Stryjecka-Zimmer M
    Neurol Neurochir Pol; 2006; 40(5):404-12. PubMed ID: 17103354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 2000 May; 46(2):214-24. PubMed ID: 10773225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes.
    Young DA; Gavrilov S; Pennington CJ; Nuttall RK; Edwards DR; Kitsis RN; Clark IM
    Biochem Biophys Res Commun; 2004 Sep; 322(3):759-65. PubMed ID: 15336529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Roles of matrix metalloproteinases and tissue specific inhibitors of metalloproteinases in dentinogenic ghost cell tumor and ghost cell odontogenic carcinoma].
    Geng N; Ban Y; Chen Y; Yang MZ; Bao DM; Yi XZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):756-60. PubMed ID: 19134356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.